Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion.

Jeong Uk LimChang Dong YeoHye Seon KangChan Kwon ParkJu Sang KimJin Woo KimSeung Joon KimSang Haak Lee

Published in: PloS one (2018)

A combination of pretreatment LMR and platelet levels can be used to predict short survival in stage IV NSCLC patients who underwent active anticancer treatment.

Keyphrases

end stage renal disease
peripheral blood
ejection fraction
small cell lung cancer
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
dendritic cells
smoking cessation